SEC Form 4/A · accession 0001209191-17-031416
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Virinder Nohria
Director
Period of report
May 3, 2017
Accepted (ET)
May 10, 2017 · 7:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | May 3, 2017 | M | 13,953 | — | A | 19,211 | I | By Trust |
| Ordinary Shares | holding | — | — | — | 189,836 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | May 3, 2017 | M | 13,953 | D | — | — | Ordinary shares | 13,953 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- F2On May 3, 2016, the reporting person was granted 13,953 restricted stock units, vesting in full on the first anniversary of the grant date.
Remarks
The Form 4 filed on May 4, 2017 is hereby corrected to remove the restricted stock units and stock option which were erroneously reported on such Form and to check the Section 16 exit box. The reporting person's term as a director of the Issuer ended on May 3, 2017, and consequently, he did not receive new stock awards.